Brief: Cabaletta Bio Q2 net income USD -14.487 million
10/08/2023 12:33
Aug 10 (Reuters) - Cabaletta Bio Q2 operating expenses USD 15.89 million. * Q2 net income USD -14.487 million * Q2 income from operations USD -15.89 million
Recent news on Cabaletta Bio
See all newsBrief: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cabaletta Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cabaletta Bio Q2 net loss widens as R&D costs rise
Cabaletta Bio, Inc. expected to post a loss of 37 cents a share - Earnings Preview
Cabaletta Bio Inc expected to post a loss of 37 cents a share - Earnings Preview